Xylometazoline loaded chitosan nanoparticles: fabrication, optimization and evaluation for nasal congestion
By: Attri, Kavita
.
Contributor(s): Singh, Manvi.
Publisher: Karnataka Association of Pharmaceutical Teachers of India (APTI) 2022Edition: Vol.56(3), Jul-Sep.Description: 716-722p.Subject(s): PHARMACEUTICSOnline resources: Click here
In:
Indian journal of pharmaceutical education and researchSummary: Aim: The present study aims at exploring the development of xylometazoline hydrochloride
loaded chitosan nanoparticles (XYL-NP) cross linked with calcium chloride for the
treatment of nasal congestion. Materials and Methods: XYL-NP were prepared using
different polymer like chitosan, cross linking agent calcium chloride and glacial acetic
acid as a solvent enhancer using ionotropic gelation method, which was further optimized
and validated by Box-Behnken Design. Further, these particles were characterised for
size, morphology and evaluated for its release and permeability studies. Results: XYL-NP
showed a particle size of 172+0.4 nm and a PDI of 0.27. The obtained charged
nanoparticles showed encapsulation efficiency of 90.5%. Transmission Electron
Microscopy (TEM) and Scanning Electron Microscopy (SEM) studies showed nanoparticles
have small size and smooth morphology and an
in-vitro drug release of 81.2 %, following
Peppas-korsemeyer release model.96.3% of the drug was permeated through the nasal
mucosa of the goat in a time period of 8 hr. Conclusion: Release and permeation results
shows the capability of the nanoparticles to retain large amount of XYL-NP inside the
mucosa. Hence XYL-NP can be used in treating nasal congestion as the fabricated
formulation has good bioadhesive and mucoadhesive property.
| Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
Articles Abstract Database
|
School of Pharmacy Archieval Section | Not for loan | 2022-1378 |
Aim: The present study aims at exploring the development of xylometazoline hydrochloride
loaded chitosan nanoparticles (XYL-NP) cross linked with calcium chloride for the
treatment of nasal congestion. Materials and Methods: XYL-NP were prepared using
different polymer like chitosan, cross linking agent calcium chloride and glacial acetic
acid as a solvent enhancer using ionotropic gelation method, which was further optimized
and validated by Box-Behnken Design. Further, these particles were characterised for
size, morphology and evaluated for its release and permeability studies. Results: XYL-NP
showed a particle size of 172+0.4 nm and a PDI of 0.27. The obtained charged
nanoparticles showed encapsulation efficiency of 90.5%. Transmission Electron
Microscopy (TEM) and Scanning Electron Microscopy (SEM) studies showed nanoparticles
have small size and smooth morphology and an
in-vitro drug release of 81.2 %, following
Peppas-korsemeyer release model.96.3% of the drug was permeated through the nasal
mucosa of the goat in a time period of 8 hr. Conclusion: Release and permeation results
shows the capability of the nanoparticles to retain large amount of XYL-NP inside the
mucosa. Hence XYL-NP can be used in treating nasal congestion as the fabricated
formulation has good bioadhesive and mucoadhesive property.
Click on an image to view it in the image viewer
There are no comments for this item.